Athenex Inc (ATNX)

3.75 -0.23  -5.78% NASDAQ Jul 23, 16:59 USD
View Full Chart
Price Chart
View All ATNX News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
08/06/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/18/2021 09:30 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
03/01/2021 Earnings Results Q4 2020 Earnings Results
03/01/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
11/05/2020 08:00 EST Earnings Calls Q3 2020 Earnings Call
08/06/2020 08:00 EST Earnings Calls Q2 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting preclinical and clinical testing, recruiting personnel, identifying and evaluating additional drug candidates for potential in-licensing or acquisition, and raising capital to support development and commercialization activities.
  • URL: https://www.athenex.com
  • Investor Relations URL: https://ir.athenex.com/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F0000155EU ST Healthcare Innovations 9 F CA 1.88%
F000014EGP ST Healthcare Innovations 8 CA 1.33%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.